P III experimental Boehringer Ingelheim compound
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for P III experimental Boehringer Ingelheim compound, covering 2011-08-02 to 2011-08-02. Get the full timeline:
Most recent: Clinical Trial Update: Japanese P III vs Voglibose and Placebo [Phase 3]